Legendary soul singer Jerry Butler, known as "The Iceman," has passed away at 85, leaving behind an unforgettable legacy in ...

Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.

CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to ...

John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...

Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...

A recent study by Queen Mary University of London suggests that antiepileptic drugs may be linked to an increased risk of ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

Dr. Cheng's team continues to explore AI's potential in drug repurposing for neurodegenerative diseases. Their findings suggest that reducing cholesterol, glucose levels and blood pressure through ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential for healthcare implementation.

A research team in North Wales is calling for volunteers with Parkinson’s disease (PD) to take part in a trial testing a device that may improve walking and reduce the risk of falls.